Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. MET Research, Inc.
483
•MET Research, Inc.•June 8, 2026

FDA 483 - MET Research, Inc. - June 08, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MET Research, Inc.
Record Details

Charles River Laboratories in Mattawan, MI, a nonclinical laboratory, received a Form 483 with one observation. The inspection found that the study director failed to ensure the proper transfer of all study materials to archives at the close of a study. Additionally, the study director did not document an exception from regulations in the final report's compliance statement.

Company
MET Research, Inc.
Inspection Date
June 8, 2026
Product Type
Other
Office
Division of Pharmaceutical Quality Operations III
Person
  • Chelsea W. Lamm (investigator)
Open in Dashboard

ID · ae3eec8b-5fef-4974-b825-81bfcb0ea33e

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.